Шай Розенберг

Доктор Шай Розенберг - специалист в области нейроонкологии,  руководитель лаборатории вычислительной биологии онкологических заболеваний.

Должность: Нейроонколог
Языки: Английский
Принимает: только взрослых

Доктор Шай Розенберг - специалист в области нейроонкологии,  руководитель лаборатории вычислительной биологии онкологических заболеваний.

Научные публикации

Parental perspectives on pain detection, assessment, and management in their highly dependent children with cerebral palsy: A cross-sectional study
Fungal peritonitis in peritoneal dialysis patients: a nationwide cohort study
Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study
Graph convolution networks model identifies and quantifies gene and cancer specific transcriptome signatures of cancer driver events
Tumor analysis of BRCA carriers reveals genomic similarities although separated by time
Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study
Cancer mutational signatures identification in clinical assays using neural embedding-based representations
Epidemiology and Treatment Patterns of Patients with Vitiligo: A Real-World Analysis
Multimodal Machine Learning for Prediction of 30-Day Readmission Risk in Elderly Population
Fibroblast growth factors induce hepatic tumorigenesis post radiofrequency ablation
Both cell autonomous and non-autonomous processes modulate the association between replication timing and mutation rate
Mutational signatures association with replication timing in normal cells reveals similarities and differences with matched cancer tissues
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries
Distinct breast cancer phenotypes in BRCA 1/2 carriers based on ER status
Concordance between cancer gene alterations in tumor and circulating tumor DNA correlates with poor survival in a real-world precision-medicine population
Shared Cancer Dataset Analysis Identifies and Predicts the Quantitative Effects of Pan-Cancer Somatic Driver Variants
Combined hepatocellular-cholangiocarcinoma derives from liver progenitor cells and depends on senescence and IL-6 trans-signaling
Identification of growth hormone receptor as a relevant target for precision medicine in low-EGFR expressing glioblastoma
High throughput SARS-CoV-2 variant analysis using molecular barcodes coupled with next generation sequencing
GIMAP6 regulates autophagy, immune competence, and inflammation in mice and humans
Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma
Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care
ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data
TP53_PROF: a machine learning model to predict impact of missense mutations in TP53
Cancer Mutational Processes Vary in Their Association with Replication Timing and Chromatin Accessibility
Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma
Continuous Remote Patient Monitoring Shows Early Cardiovascular Changes in COVID-19 Patients
Asthma in Youth and Early-onset Type 2 Diabetes: A Nationwide Study of 1.72 Million Israeli Adolescents
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
Multiple Roles of IL6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress Tumorigenesis
Rare deleterious mutations of HNRNP genes result in shared neurodevelopmental disorders
Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel
The Human Phenotype Ontology in 2021
Comprehensive assessment of TP53 loss of function using multiple combinatorial mutagenesis libraries
The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma
Survival Implications of the Relationship between Tissue versus Circulating Tumor DNA TP53 Mutations-A Perspective from a Real-World Precision Medicine Cohort
Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
Repeated Intravenous Amantadine Infusions in Advanced Parkinsonism: Experience of a Large Movement Disorder Center
Door To Detorsion Time Determines Testicular Survival
A direct interaction between survivin and myosin II is required for cytokinesis
High prevalence of cancer-associated TP53 variants in the gnomAD database: A word of caution concerning the use of variant filtering
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
The impact of R353Q genetic polymorphism in coagulation factor VII on the initial anticoagulant effect exerted by warfarin
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma
Machine Learning for Better Prognostic Stratification and Driver Gene Identification Using Somatic Copy Number Variations in Anaplastic Oligodendroglioma
A recurrent point mutation in PRKCA is a hallmark of chordoid gliomas
Ex-vivo organ culture as potential prioritization tool for breast cancer targeted therapy
Correction to: ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma
Показать ещё 42 статьи Скрыть статьи
Заболевания
Глиобластома
Опухоли головного мозга
Первичная лимфома центральной нервной системы
Остались вопросы?
Напишите нам и мы свяжемся с вами в течение ближайшего времени и ответим на все интересующие вопросы